|
HS Code |
128714 |
| Chemical Name | Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine |
| Molecular Formula | C36H36N10 |
| Molecular Weight | 592.74 g/mol |
| Cas Number | 936992-88-8 |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO, DMF, and methanol |
| Purity | Typically ≥ 95% |
| Melting Point | 130-135 °C (approximate) |
| Storage Temperature | 2-8 °C (refrigerated) |
| Smiles | c1ccc(cc1)Cn2cnnn2CCN(CCn3cnnn3Cc4ccccc4)CCn5cnnn5Cc6ccccc6 |
| Inchi Key | WGIGKNFMIGVEQY-UHFFFAOYSA-N |
As an accredited Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, 1g, is supplied in a sealed amber glass vial with a screw cap. |
| Shipping | **Shipping Description:** Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine is shipped in sealed containers designed to prevent moisture and air exposure. Standard shipping is at ambient temperature, unless otherwise specified by safety data. Ensure compliance with all local chemical regulations. Chemical-grade material is handled with caution to avoid contamination or degradation during transit. |
| Storage | Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine should be stored in a tightly sealed container, protected from light and moisture, at room temperature (15–25°C). Keep it in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizing agents. Follow standard safety protocols, and refer to the manufacturer’s Material Safety Data Sheet for specific storage guidelines. |
Competitive Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the field of specialty chemical synthesis, the arrival of new ligands and supporting compounds often means the difference between decent output and exceptional reliability. Many years ago, our focus sharpened on producing Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, not as a generic product offering, but as a response to bottlenecks laboratories face with challenging copper-catalyzed azide-alkyne cycloaddition (CuAAC) and other click reactions. While other suppliers highlight stock lists, our interest lies in solving recurring problems with reproducibility, batch clarity, and secondary impurity removal.
We have found that real progress requires attention to detail at every point, right down to the control of side products that change the activity of the ligand, and consequently, the activity of the copper catalyst it coordinates. Our process, refined over several years, has tracked each step of triazole ring formation and the precise attachment of the benzylic group, so waste byproducts are held to a minimum, and analytical profiles hit the mark every run. Labs using this compound usually apply it in catalytic systems, so controlling trace metal content, moisture load, and batch-to-batch composition matters enormously for them.
As a ligand, Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine brings together three triazole rings linked through methylene bridges to a central amine. The benzyl groups on the triazole rings do more than decorate the structure: they set the stage for better solubility in a wider range of solvents and dampen background reactivity that plagues other ligands in this class. This is not purely theory—over years of scale-ups, we have run hundreds of tests, and see time and again how the benzyl groups reduce undesired side reactions in click chemistry assemblies.
For those in bioconjugation, surface modification, or polymer cross-linking, this ligand gives strong, highly consistent coordination to copper catalysts. You see it in cleaner reaction profiles on chromatography, and in photometric data, with less background absorbing material. These results don’t come by chance. They come from a process built around high-purity triazole ring formation and exhaustive HPLC and NMR verification before packing. Only lots where benzyl substitution and overall purity exceed 99% move to fill requests.
We hear often from chemists, both academic and industrial, about frustration over unpredictable outcomes and catalysis failures traced not to their own technical approach, but to instability, impurities, or variant structures in the ligand. One of the repeating problems with other available ligands—either non-benzylated versions or tridentate variants—is their persistent inclusion of regioisomeric triazoles, leading to ambiguous coordination and scrambling of product mixtures. What’s worse, resin- or template-prepared triazoles, often from outside sources, can bring in unwanted phosphine residues or halides that interact with the copper and radically reduce catalyst efficiency.
We target these weak links directly. Our Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine consistently exceeds accepted purity markers, including sub-0.1% levels of inorganic residue and tightly controlled heavy metal content. After seeing a year of lost yields from impure ligands, one pharmaceutical process team shared their switch in catalyst protocol only once they sourced our product; post-reaction analytics confirmed their side products dropped sharply, and they avoided two months of re-purification that had previously cost them key delivery deadlines.
Many people overlook how small changes in ligand structure carry through to the chemical workflow. From the first days we began making this compound, we pursued a route that builds from high-grade benzyl azide and propargylamine, running CuAAC under oxygen-controlled conditions to suppress off-pathway cycloaddition. Our batches face environmental monitoring for residual copper and solvents, as trace contaminants can completely throw off bio-orthogonal coupling steps further down the line.
In our experience, those working with biopolymers or in the development of diagnostic probes demand detection-level clarity in both the major ligand and in the trace inorganics accompanying it. Even 0.5% excess of branched triazole ring or N,N'-linked impurities that often escape less exacting process control disrupt signal fidelity in final applications, whether in a spectrometer or in a physiological context. Purifying these out, especially at kilo-lot scale, taught us to develop a multilayered silica and charcoal filtration regime, matched to each new batch, driving down variance between bottles.
The triazole ligand world is crowded. Many available supports deploy methyl, ethyl, or even longer alkyl chains on their triazole rings, and a quick scan of suppliers can turn up dozens of such products at various price points. We've studied these in both our own work and through client feedback. Across nearly all side-by-side comparisons, unbenzylated analogues fail to deliver the same solubility in both polar and nonpolar solvents, and they fall short when even trace water finds its way into the system. Chemists chasing reproducibility often tell us that switchovers to our benzylated ligand removed persistent haze and color in both small-molecule and bio-conjugated products.
The difference comes down to how the benzyl groups shield the triazole core, reducing random interaction with ambient oxygen, and how this affects both storage stability and catalytic microenvironments. Our process relies on confirmed lot-to-lot NMR patterns, which verify all three benzyl groups attached through the correct triazole nitrogen, without scrambling or ring-opening. This attention to clean, exclusive formation keeps the kinetic and thermodynamic profiles predictable, which in turn empowers users to set tighter process parameters without worrying about drifting outcomes.
Producing Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine at scale introduced its own difficulties, which we only resolved by tracing impurities right back to the precursor step. Early efforts delivered ligands that seemed bright and pure on TLC, yet under close scrutiny, contaminants from improperly washed copper(II) sulfate or sodium ascorbate came out in elemental analysis and downstream application. One especially frustrating month, a litany of inconsistent copper-catalyzed couplings came across our support line, each eventually traced to a particular batch from the market that proved variable in trace copper and incomplete benzylation.
Learning from these costly experiences, our team restructured the workup and filtration process. Today, every batch passes freeze-drying and sequential solvent gradient washes, which eliminate occluded salts and minimize product loss. Final tests involve both independent spectral analysis and small-scale reaction trials that mirror how research and pilot labs deploy the ligand in actual catalysis. We maintain an in-house program that re-tests retained lots at regular intervals, verifying long-term shelf stability and lot uniformity by full analytical reruns, a step that catches degradation or eventual micro-impurity formation before anything leaves for a client lab.
Chemists know the real pain of chasing a stalled reaction, only to spend days trouble-shooting, swapping solvents, even buying new copper salts, when the problem turns out to be a subtle impurity in the ligand. For ligands like Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, a supplier's expertise in the actual manufacturing process does more to guarantee successful use in practice than any spec sheet or re-packaged lot. Our best recommendations come from users needing consistent yields, time and again, in both batch and continuous processes.
One university collaboration, working on a PEGylated protein linker, struggled with background color and unexpected molecular weight species until switching over to our benzylated triazole ligand. Their mass spectrometry and functional testing confirmed a ten-fold drop in unintended crosslinking. This kind of outcome doesn't arrive from a theoretical commitment to purity; it comes from hands-on control of every production detail, from glassware washing, through batch monitoring, to final shipping.
Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine has found new homes across several leading-edge applications, reaching further than click chemistry. As advances drive the demands of bioconjugation, targeted therapy, and nanoscale assembly, its role has moved beyond a supporting reagent and into the heart of building up reliable diagnostic, delivery, and sensor technologies.
In our own labs, we have used the ligand to prototype new generations of DNA-attached fluorophores, anchoring quantum dots for research into cellular imaging. Our custom process keeps end-caps and side reactions under control, so each run produces DNA conjugates with clear, single-peak profiles instead of mixed populations. Chemical engineers working with surface grafting have written to us, noting faster, higher-fidelity click-on rates, and the avoidance of fouling or post-run scumming common with less well-defined ligands. Large pharma partners have steadily increased orders as assurance piles up from previous lots, keeping their drug candidate timelines consistent.
Standard batch record-keeping is not enough in a field where a single variable can change the outcome of an entire study or manufacturing campaign. Our teams keep sample retention vials from each production run, building up a library that gives us traceability down to the bottle received by a specific research program. This gives labs working at the research or regulatory forefront a robust fallback, should they ever spot an unexpected outcome that needs explanation.
Our full analytical profiles, with repeated NMR and HPLC, are mapped against each new production lot. We encourage researchers to share detailed feedback—coupling efficiencies, side product profiles, chromatograms—so that any outlier event is matched quickly to its root cause. This open loop between manufacturing and field results guarantees rapid improvement and swift troubleshooting.
Over the last decade, ligand sourcing moved from a commodity model toward one that rewards thorough process control and direct relationship between end users and primary manufacturers. We saw the negative impacts of opaque supply chains: resellers pass on lots with varying, untested batch histories, leading to wild swings in catalysis or bioconjugation outcomes. Our philosophy, born from years of trial and response, centers on accountability at every synthetic step and direct feedback to our own teams.
One discovery that made a visible difference came after a series of user complaints traced to a subtle difference between storage atmospheres in shipping versus warehouse holding. Introducing nitrogen flushing and custom thermal-padded containment stopped micro-level hydrolysis in some of our most moisture-sensitive lots, sustaining purity even at the final point of use. Practical discoveries like these only arise from living with and responding to the full product lifecycle, not just the synthetic chemistry upfront.
True process advancement means weighing more than just yield metrics. In our work, solvent volatility, heavy metal waste, and energy use matter. We have gradually replaced legacy solvents with safer, lower-impact alternatives wherever data supports the swap and worked with partners on closed-loop solvent recovery. Reclaiming copper from spent catalyst runs and refining it back for use in further synthesis is a project that began as a test, but now forms a regular part of several batch cycles, reducing environmental footprint and dependency on new raw materials.
Safety practice extends further than just tick-boxes or checklist compliance. Real-world incidents—like a vapor leak during triazole cyclization, or an unexpected exotherm when scaling new lots—shaped our operating procedures. Each documented event led to a case review and upgrade process, not only improving safety in our plant, but also contributing to sounder advice given to end users handling larger lots in their own environments. Our safety sheets translate experience drawn directly from the production and purification reality rather than stock templates.
Chemists, whether in a small-scale lab or a process-scale facility, often balance experiment risk with the need for reliable reagents. Through our years working with Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, we have seen both the promise and the pitfalls faced by those who dare to scale up or push applications further. Supplying this ligand directly from our production floor means the full expertise of those who synthesize, purify, and analyze each batch is available to help in troubleshooting, new method development, or special project requirements.
We continue to invest in both capacity and quality, tracking developments in synthetic methodology and catalyst engineering. Through direct collaboration with universities, contract research organizations, and industry partners, the performance of each lot goes beyond simple numbers to impact innovation directly. This culture of feedback and refinement, and willingness to reinvent processes as new data emerges, reinforces why Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine remains a trusted building block in many labs worldwide.
Chemical manufacturing, in reality, is not a matter of issuing certificates and ticking purity columns. It is an ongoing process of controlled adaptation, learning from each production run, and staying responsive to the challenges chemists face in every type of research and development environment. Our work with Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine reflects a long-term commitment to both reliable production and innovation that unlocks new possibilities for science and industry.
Real progress doesn’t come from the easiest path, but from persistent attention to what matters: structure, purity, predictability, and above all, open communication between those who make the reagents and those who bring them to life in new applications. With this philosophy, we look forward to the next decade of developments—new methods, new applications, and new challenges—for which robust, well-made ligands will always be essential.